Virtus ETF Advisers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23K Hold
41
0.01% 436
2025
Q4
$27.7K Sell
41
-200
-83% -$136K 0.01% 423
2025
Q3
$154K Buy
+241
New +$146K 0.08% 246
2024
Q2
Sell
-1,429
Closed -$772K 464
2024
Q1
$772K Buy
1,429
+62
+5% +$33.9K 0.41% 104
2023
Q4
$759K Buy
1,367
+20
+1% +$9.39K 0.48% 20
2023
Q3
$589K Sell
1,347
-226
-14% -$113K 0.36% 150
2023
Q2
$790K Buy
+1,573
New +$754K 0.47% 67
2022
Q3
Sell
-1,525
Closed -$535K 455
2022
Q2
$535K Buy
+1,525
New +$622K 0.2% 221
2018
Q4
Sell
-69
Closed -$17K 348
2018
Q3
$17K Buy
+69
New +$16.7K ﹤0.01% 290

Other funds holding IDXX

Virtus ETF Advisers's IDXX Position: Q1 2026 in Review

Virtus ETF Advisers held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 41 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #436.

Virtus ETF Advisers first reported a position in IDXX in Q3 2018 and has held it in 9 quarters since. The position peaked at $790K in Q2 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Virtus ETF Advisers held 41 shares of Idexx Laboratories worth $23K as of Q1 2026.
  • Virtus ETF Advisers left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.01% of Virtus ETF Advisers's portfolio in Q1 2026, its #436 holding.
  • Virtus ETF Advisers first reported a position in Idexx Laboratories in Q3 2018 and has held it in 9 quarters since.
  • Virtus ETF Advisers's Idexx Laboratories position peaked at $790K in Q2 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.